Kestra Medical Technologies (KMTS) Accumulated Expenses (2024 - 2026)

Kestra Medical Technologies (KMTS) has reported Accumulated Expenses for 3 consecutive years, with $23.0 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Accumulated Expenses rose 4824.36% year-over-year to $23.0 million; the TTM figure through Apr 2026 stood at $23.0 million (up 4824.36% YoY), while the FY2026 annual figure was $23.0 million, up 4824.36% from the prior year.
• Accumulated Expenses rose to $23.0 million in Q2 2026 per KMTS's latest filing, from $1.1 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $23.0 million in Q2 2026 and bottomed at $234000.0 in Q2 2024.
• Historically, Accumulated Expenses has averaged $5.9 million across 3 years, with a median of $1.1 million in 2026.
• On a YoY basis, Accumulated Expenses climbed as much as 4824.36% in 2026 and fell as far as 46.32% in 2026.
• Kestra Medical Technologies' Accumulated Expenses stood at $234000.0 in 2024, then jumped by 89.32% to $443000.0 in 2025, then surged by 5102.26% to $23.0 million in 2026.
• Business Quant data shows KMTS's Accumulated Expenses at $23.0 million in Q2 2026, $1.1 million in Q1 2026, and $443000.0 in Q4 2025.